$The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection$

The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2020-10, Vol.34 (10), p.2790-2793
Hauptverfasser:	Lai, Peilong, Chen, Xiaomei, Qin, Le, Jiang, Zhiwu, Luo, Chenwei, Huang, Xin, Wu, Sujing, Ling, Wei, Wang, Yulian, Wang, Jinghua, Deng, Chenxin, Huang, Lisi, Zeng, Lingji, Lu, Zesheng, Zhong, Liye, Liao, Pengjun, Li, Minming, Chen, Dongmei, Geng, Suxia, Wu, Ping, Tang, Zhaoyang, Pei, Duanqing, Du, Xin, Li, Peng, Weng, Jianyu
Format:	Artikel
Sprache:	eng
Schlagworte:	14/5 631/250/251 64/60 692/700/565/251 Animals Cancer Research Cell therapy Critical Care Medicine Development and progression Disease Models, Animal Female Health aspects Hematology Hepatitis B Hepatitis B - complications Hepatitis B - diagnosis Hepatitis B - immunology Hepatitis B - virology Hepatitis B virus - immunology Humans Immunotherapy, Adoptive - adverse effects Immunotherapy, Adoptive - methods Intensive Internal Medicine Letter Lymphocytes Lymphocytes T Male Medicine Medicine & Public Health Mice Middle Aged Oncology Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy Receptors, Antigen, T-Cell Receptors, Chimeric Antigen T cells T-Lymphocytes - immunology T-Lymphocytes - metabolism Treatment Outcome Xenograft Model Antitumor Assays
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0887-6924 1476-5551
DOI:	10.1038/s41375-020-0952-4